Figure 3.
Percentage of non-MenB strains showing hSBA ≥2 with adolescent 4CMenB- (solid colored fill) and infant (dotted colored fill) 4CMenB immune sera
Percentage of non-MenB strains showing hSBA ≥2 with adolescent 4CMenB- (solid colored fill) and infant (dotted colored fill) 4CMenB immune sera